IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Hovsepian, Eugenia ^a   Penas, Federico ^a   Siffo, Sofía ^a   Mirkin, Gerardo A ^a   Goren, Nora B ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELLS, CULTURED; INTERLEUKIN-10; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MYOCYTES, CARDIAC; NF-KAPPA B; PHOSPHORYLATION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRYPANOSOMA CRUZI;

EID: 84894157947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079445     Document Type: Article

References (58)

1. Abrahamsohn IA, Coffman RL (1995) Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol. 155: 3955-3963.
2. Chandrasekar B, Melby PC, Troyer DA, Colston JT, Freeman GL (1998) Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy. Am J Pathol. 152: 925-934. (Pubitemid 28173354)
3. Hovsepian E, Mirkin GA, Penas F, Manzano A, Bartrons R, et al. (2011) Modulation of inflamatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J(2) in Trypanosoma cruzi-infected cardyomyocites. Int J Parasitol. 41: 553-562.
4. Penas F, Mirkin GA, Hovsepian E, Cevey A, Caccuri R, et al. (2013) PPARγ ligand treatment inhibits cardiac inflammatory mediators induced by infection with different lethality strains of Trypanosoma cruzi. Biochim Biophys Acta.; 1832: 239-248.
5. Borges MM, Kloetzel JK, Andrade HF Jr, Tadokoro CE, Pinge-Filho P, et al. (1998) Prostaglandin and nitric oxide regulate TNF-alpha production during Trypanosoma cruzi infection. Immunol Lett. 63: 1-8. (Pubitemid 28368237)
6. Pinge-Filho P, Tadokoro CE, Abrahamsohn IA (1999) Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol. 193: 90-98. (Pubitemid 29197523)
7. Cunha-Neto E, Nogueira LG, Teixeira PC, Ramasawmy R, Drigo SA, et al. (2009) Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz. 104: 252-258.
8. Frangogiannis NG (2006) Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem. 13: 1877-1893.
9. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, et al. (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res. 102: 257-264. (Pubitemid 351674064)
10. Tao ZY, Cavasin MA, Yang F, Liu YH, Yang XP (2004) Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci. 74: 1561-1572. (Pubitemid 38077217)
11. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, et al. (2000) IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol.165: 2798-2808. (Pubitemid 30660731)
12. Yao L, Huang K, Huang D, Wang J, Guo H, et al. (2008) Acute myocardial infarction induced increases in plasma tumor necrosis factor-alpha and interleukin-10 are associated with the activation of poly (ADP-ribose) polymerase of circulating mononuclear cell. Int J Cardiol.123: 366-368. (Pubitemid 350297461)
13. Riley JK, Takeda K, Akira S, Schreiber RD (1999) Interleukin-10 Receptor Signaling through the JAK-STAT Pathway. J Biol Chem.; 274: 16513-16521.
14. Cao X, Tay A, Guy GR, Tan YH (1996) Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol. 16: 1595-1603. (Pubitemid 26095631)
15. Hong Z, Wen Z, Darnell JE Jr (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98. (Pubitemid 24144493)
16. Ponce NE, Carrera-Silva EA, Pellegrini AV, Cazorla SI, Malchiodi EL, et al. (2013) Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells. Biochim Biophys Acta. 1832: 485-494.
17. Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 386: 917-921. (Pubitemid 27289594)
18. Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, et al. (1999) Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidencefor an IL-10-induced pathway that is independent of STAT protein activation. Blood 94: 2880-2889. (Pubitemid 29477317)
19. Ding Y, Chen D, Tarcsafalvi A, Su R, Qin L, et al. (2003) Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J Immunol. 170: 1383-1391. (Pubitemid 36139505)
20. Nair S, Pandey AD, Mukhopadhyay S (2011) The PPE18 protein of Mycobacterium tuberculosis inhibits NF-κB/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein. J Immunol. 186: 5413-5424.
21. Esper L, Roman-Campos D, Lara A, Brant F, Castro LL, et al. (2012) Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. Am J Pathol.181: 130-140.
22. González Cappa SM, Bijovsky AT, Freilij H, Muller L, Katzin AM (1981) Isolation of a Trypanosoma cruzi strain of predominantly slender from Argentina. Medicina (B. Aires). 41: 119-120.
23. Hovsepian E, Penas F, Goren NB (2010) 15-deoxy-Δ12,14- ProstaglandinJ2 but no rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells. Shock 34: 60-67.
24. Schust J, Sperl B, Hollis A, Mayer TU, Berg T (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol., 13: 1235-42. (Pubitemid 44750735)
25. Goren N, Cuenca J, Martín-Sanz P, Boscá L (2004) Attenuation of NF-kappaB signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes. Cardiovasc Res. 64: 289-297. (Pubitemid 39361690)
26. Silva JS, Twardzik DR, Reed SG (1991) Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med. 174: 539-545.
27. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, et al. (1992) Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med. 175: 169-174.
28. Hunter CA, Ellis-Neyes LA, Slifer T, Kanaly S, Grünig G, et al. (1997) Fort M, Rennick D, Araujo FG. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol. 158: 3311-3316. (Pubitemid 127484048)
29. Roffê E, Rothfuchs AG, Santiago HC, Marino AP, Ribeiro-Gomes FL, et al (2012) IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J Immunol.188: 649-660.
30. Dutra WO, Rocha MO, Teixeira MM (2005) The clinical immunology of human Chagas disease. Trends Parasitol. 12: 581-587. (Pubitemid 41572271)
31. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, et al. (2003) Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun., 71: 1185-1193. (Pubitemid 36254300)
32. Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, et al. (2004) Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun. 72: 5283-5291. (Pubitemid 39223415)
33. Borges DC, Araújo NM, Cardoso CR, Chica JE (2013) Different parasite inoculums determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection. Immunology. 138: 145-56.
34. Trocoli Torrecilhas AC, Tonelli RR, Pavanelli WR, da Silva JS, Schumacher RI, et al. (2009) Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect. 11: 29-39.
35. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation. 115: 1109-1123. (Pubitemid 46679556)
36. Gutierrez FR, Lalu MM, Mariano FS, Milanezi CM, Cena J, et al. (2008) Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J Infect Dis. 197: 1468-1476. (Pubitemid 351706471)
37. Cuenca J, Martín-Sanz P, Alvarez-Barrientos AM, Boscá L, Goren N (2006) Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. Am J Pathol. 169: 1567-1576. (Pubitemid 351181989)
38. Raychaudhuri B, Fisher CJ, Farver CF, Malur A, Drazba J, et al (2000) Interleukin-10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine. 12: 1348-1355.
39. Shames BD, Selzman CH, Meldrum DR, Pulido EJ, Barton HA, et al. (1998) Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock 10: 389-394. (Pubitemid 128463860)
40. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 270: 9558-9563.
41. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, et al. (2009) IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 104: e9-e18.
42. Stahl A, Joyal JS, Chen J, Sapieha P, Juan AM, et al. (2012) SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood. 120: 2925-2929.
43. He B, You L, Uematsu K, Matsangou M, Xu Z, et al. (2003) Cloning and characterization of a functional promoter of the human SOCS-3 gene. Biochem Biophys Res Commun. 301: 386-391. (Pubitemid 36279250)
44. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, et al. (2002) Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol. 168: 6404-6411. (Pubitemid 34620065)
45. Huang N, Rizshsky L, Hauck CC, Nikolau BJ, Murphy PA, et al. (2012) The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in Hypericum perforatum extract is partially dependent on the activation of SOCS3. Phytochemistry. 76: 106-116.
46. Qasimi P, Ming-Lum A, Ghanipour A, Ong CJ, Cox ME, et al. (2006) Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages. J Biol Chem. 281: 6316-6324. (Pubitemid 43847563)
47. Veenbergen S, Bennink MB, Affandi AJ, Bessis N, Biton J, et al. (2011) A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis. Ann Rheum Dis. 70: 2167-2175.
48. Berg DJ, Davidson N, Kühn R, Müller W, Menon S, et al. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest. 98: 1010-20. (Pubitemid 26293320)
49. Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol. 44: 607-14. (Pubitemid 26400375)
50. van Roon J, Wijngaarden S, Lafeber FP, Damen C, van de Winkel J, et al. (2003) Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation. J. Rheumatol. 30: 648-51. (Pubitemid 36402754)
51. Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM, et al. (2010) IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol. Lett. 127: 150-6.
52. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, et al. (1994) IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol. 153: 3135-40. (Pubitemid 24292538)
53. Alba Soto CD, Solana ME, Poncini CV, Pino-Martinez AM, Tekiel V, et al. (2010) Dendritic cells devoid of IL-10 induce protective immunity against the protozoan parasite Trypanosoma cruzi. Vaccine. 28: 7407-13.
54. Guedes PM, Veloso VM, Afonso LC, Caliari MV, Carneiro CM, et al. (2009) Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase. Vet. Immunol. Immunopathol. 130: 43-52.
55. Roffê E, Rothfuchs AG, Santiago HC, Marino AP, Ribeiro-Gomes FL, et al. (2012) IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J. Immunol. 188: 649-60.
56. de Araújo FF, Vitelli-Avelar DM, Teixeira-Carvalho A, Antas PR, Assis Silva Gomes J, et al. (2011) Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl. Trop Dis. 5(5): e992.
57. de Araújo FF, Corrêa-Oliveira R, Rocha MO, Chaves AT, Fiuza JA, et al. (2012) Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity. Immunobiology. 217: 768-77.
58. de Melo AS, de Lorena VM, de Moura Braz SC, Docena C, de Miranda Gomes Y (2012) IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi. Cytokine. 58: 207-12.